Covered recipient · General Payments record
SUH H YANG
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$500.04
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.31 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $70.82 | 3 |
| ABBVIE INC. | $61.90 | 3 |
| Acerta Pharma LLC | $50.35 | 3 |
| Novo Nordisk AS | $36.93 | 2 |
| Lilly USA, LLC | $22.38 | 1 |
| Exact Sciences Corporation | $18.68 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.17 | 1 |
| Retrophin, Inc. | $6.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.85 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010299897 | CMS |
| ABBVIE INC. | $24.53 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010299901 | CMS |
| ABBVIE INC. | $14.52 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010299905 | CMS |
| Amgen Inc. | $22.50 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020805661 | CMS |
| Amgen Inc. | $29.71 | 09/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020805663 | CMS |
| Amgen Inc. | $18.61 | 12/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020805665 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.47 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015741035 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.77 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015428681 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.11 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014605835 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.17 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997062385 | CMS |
| Exact Sciences Corporation | $18.68 | 11/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026827825 | CMS |
| Lilly USA, LLC | $22.38 | 08/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033740257 | CMS |
| Novo Nordisk Inc | $21.75 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002502457 | CMS |
| Novo Nordisk Inc | $15.18 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002502445 | CMS |
| Travere Therapeutics, Inc. | $6.08 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059613589 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.